Pfizer informs about unaudited financial results

05 Aug 2022 Evaluate

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Pfizer has submitted the unaudited financial results for the quarter ended June 30, 2022, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 12:00 noon and concluded at 2:45 pm. The company has enclosed the Limited Review Report by our Auditors Walker Chandiok & Co LLP, in respect of the above results.

The above information is a part of company’s filings submitted to BSE.

Pfizer Share Price

4192.00 -212.95 (-4.83%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.